10 For 10: Top Compliance Stories For the Week Ending, August 2, 2025
Daily Compliance News: July 30, 2025, The Corruption Kill Business Edition
Investment Opportunities in Italy's Tech Market
Exploring Employment Law Across Borders: Italy vs. US With White Lotus — Hiring to Firing Podcast
Life with GDPR - Clearview AI Redux
Energy Horizons: Developing solar in Italy – key insights and practical market considerations
JONES DAY TALKS®: Private Antitrust Litigation in Italy
Jones Day Talks: Italy Embraces Foreign investment but Maintains Oversight
Celltrion’s ustekinumab biosimilar, STEQEYMA®, has won its first bid within 2 months of its launch in January of 2025. Since launch, STEQEYMA® has secured contracts in four regions of Italy, including, Piemonte, Valle...more
A paper published in the Generics and Biosimilars Initiative Journal reports on “an overview of the available real-world data about the pattern of use and the comparative effectiveness of biosimilars and originator biological...more